An Open Label Study to Compare the Oral Bioavailability of a Solid Dose Formulation of GLPG0259 Relative to an Oral Solution After Single-dose Intake in Healthy Subjects and to Evaluate the Effect of Food on the Solid Dose Formulation.
Phase of Trial: Phase I
Latest Information Update: 01 Sep 2012
At a glance
- Drugs GLPG 0259 (Primary)
- Indications Rheumatoid arthritis
- Focus Pharmacokinetics
- 23 Feb 2010 Status changed from active, no longer recruiting to completed, according to a Galapagos media release.
- 05 Dec 2009 New trial record